Leping Li, PhD

Vice President, Discovery

Dr. Li has more than 20 years of experience in drug discovery and early development, leading project teams and advancing multiple programs from early lead identification to advanced clinical development across several therapeutic areas. Dr. Li joined Assembly from antiviral drug developer Presidio Pharmaceuticals, where he was Vice President of Chemistry and inventor of the HCV NS5A inhibitor ravidasvir. Previously, he was Scientific Director in Medicinal Chemistry at Amgen, where he received the 2004 Robert A. Swanson Distinguished Employee Award. Before Amgen, Dr. Li served as a Research Investigator at Abbott Laboratories. Dr. Li obtained a BS from Shandong University in China. He earned a PhD in Organic Chemistry at Rice University and conducted postdoctoral research at Stanford University.